Non-intubated Versus Intubated Anesthesia in Thoracoscopic Esophagectomy for Esophageal Cancer
NCT07104838 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2025-09-25
Summary
This is a prospective, single-center, non-inferiority randomized controlled trial designed to evaluate the perioperative safety and feasibility of non-intubated spontaneous ventilation anesthesia (NIV) compared to conventional intubated mechanical ventilation anesthesia (IMV) in patients undergoing thoracoscopic esophagectomy for esophageal cancer. The study will be conducted at the First Affiliated Hospital of Guangzhou Medical University and aims to assess whether the non-intubated approach can offer comparable or better outcomes in terms of intraoperative and postoperative complications, anesthetic drug consumption, recovery parameters, and overall postoperative rehabilitation.
Eligible patients aged 18 to 75 years with resectable middle or lower thoracic esophageal squamous cell carcinoma or adenocarcinoma (stage I-III) will be randomly assigned (1:1) to receive either NIV using a laryngeal mask airway or IMV with a double-lumen endotracheal tube. Both groups will undergo the same thoracoscopic and laparoscopic surgical procedures, and anesthesia will be managed with standardized protocols. The primary outcome is the incidence of intraoperative and postoperative complications, including hypoxemia, hypercapnia, respiratory failure, and the need for conversion to intubation. Secondary outcomes include anesthetic drug dosage, intraoperative hemodynamic stability, postoperative pain scores, time to ambulation, length of hospital stay, and 30-day readmission rate.
This trial complies with the Declaration of Helsinki. Written informed consent will be obtained from all participants prior to enrollment.
Conditions
- Esophageal Cancer (EsC)
Interventions
- PROCEDURE
-
Non-intubated spontaneous ventilation anesthesia
Non-intubated spontaneous ventilation anesthesia
Sponsors & Collaborators
-
The First Affiliated Hospital of Guangzhou Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-01
- Primary Completion
- 2026-08-01
- Completion
- 2026-12-01
More Related Trials
-
Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy .
NCT04652180 ·Status: RECRUITING ·Phase: NA
-
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
NCT05504265 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study
NCT05028231 ·Status: UNKNOWN
-
Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer
NCT01463501 ·Status: UNKNOWN ·Phase: PHASE2
-
Perioperative Outcomes and Survival of Inflatable Video-Assisted Mediastinoscopic Transhiatal Esophagectomy for Selected Esophageal Cancer
NCT07182266 ·Status: COMPLETED
-
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NCT06912074 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NCT06602843 ·Status: RECRUITING ·Phase: NA
-
Assessment of Minimally Invasive Surgery for Esophageal Cancer
NCT05662644 ·Status: UNKNOWN ·Phase: NA
-
Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0
NCT01398449 ·Status: UNKNOWN ·Phase: PHASE3
-
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
NCT05894369 ·Status: RECRUITING
-
Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE
NCT02309619 ·Status: UNKNOWN ·Phase: NA
-
Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy
NCT01544790 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc
NCT05604664 ·Status: COMPLETED
-
A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer
NCT03428074 ·Status: COMPLETED
-
Minimally Invasive Intrathoracic Esophagogastric Side to Side Anastomosis vs. End to Side Anastomosis
NCT05812495 ·Status: UNKNOWN ·Phase: NA
-
Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma
NCT04174079 ·Status: RECRUITING ·Phase: NA
-
A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06354530 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years
NCT05604950 ·Status: COMPLETED
-
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
NCT06960889 ·Status: ACTIVE_NOT_RECRUITING
-
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer
NCT07015489 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy
NCT04513418 ·Status: RECRUITING ·Phase: PHASE3
-
Neoadjuvant Treatment Modalities in Esophageal Cancer
NCT04821843 ·Status: RECRUITING ·Phase: PHASE3
-
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
NCT07317609 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
NCT05213312 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer
NCT01998230 ·Status: COMPLETED ·Phase: PHASE3